title: Effect of transforming growth factor-beta 1 on the insulin-like growth factor system in cultured porcine Leydig cells.
abstract: Using as a model system, primary cultures of porcine Leydig cells, we have shown that transforming growth factor-beta 1 (TGF-beta 1) (2 ng/ml, 72 h) antagonizes the stimulatory action of insulin-like growth factor-I (IGF-I) on luteinizing hormone (LH/hCG) receptors. We therefore investigated the action of TGF-beta 1 on the different components of the IGF system, namely, IGF-I, II, IGF binding proteins (IGFBPs) and IGF-I receptor present in testicular Leydig cells. TGF-beta 1 was shown to decrease in a dose and time dependent manner the binding of 125I-IGF-I to Leydig cells. The maximal (40% decrease) effect was obtained with 1.3 ng/ml (0.05 nM) after 72 h of treatment. Such a decrease in IGF-I binding by TGF-beta 1 treatment was shown to be related to the number of receptor but not to their affinity. Affinity labeling of these receptors by covalently binding them to 125I-IGF-I with disuccinimidyl suberate and subsequent electrophoretic analysis of the labeled complex revealed that the inhibitory action of TGF-beta 1 (2 ng/ml, 72 h) occurs at the level of a 135 kDa protein which represents the classical form of the binding subunit of the IGF-I receptor. Moreover, our study indicates that TGF-beta 1 was unable to affect the other components of the IGF system in cultured porcine Leydig cells.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: INSERM CJF No. 90-08, Groupe de Recherche sur les Communications Cellulaires, Centre Hospitalier Lyon-Sud, Pierre Bénite, France.
authors.forename: V
authors.initials: V
authors.lastname: Besset
authors.forename: J
authors.initials: J
authors.lastname: Collette
authors.forename: M A
authors.initials: MA
authors.lastname: Chauvin
authors.forename: P
authors.initials: P
authors.lastname: Franchimont
authors.forename: M
authors.initials: M
authors.lastname: Benahmed
mesh_terms: D000345:Affinity Labels; D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism; D002478:Cells, Cultured; D003470:Culture Media; D006801:Humans; D018969:Insulin-Like Growth Factor Binding Proteins; D007334:Insulin-Like Growth Factor I / Q000378:metabolism* / Q000494:pharmacology; D007335:Insulin-Like Growth Factor II / Q000378:metabolism; D007457:Iodine Radioisotopes; D007985:Leydig Cells / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D017526:Receptor, IGF Type 1 / Q000378:metabolism; D013388:Succinimides / Q000378:metabolism; D013552:Swine; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
chemical_list: D000345:Affinity Labels; D002352:Carrier Proteins; D003470:Culture Media; D018969:Insulin-Like Growth Factor Binding Proteins; D007457:Iodine Radioisotopes; D013388:Succinimides; D016212:Transforming Growth Factor beta; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D007986:Luteinizing Hormone; D017526:Receptor, IGF Type 1; C019358:disuccinimidyl suberate